GeneDx Holdings Corp (NASDAQ: WGS) has seen a rise in its stock price by 47.51 in relation to its previous close of 11.00. However, the company has experienced a 35.22% gain in its stock price over the last five trading sessions. Seeking Alpha reported 2024-04-29 that GeneDx Holdings Corp. (NASDAQ:WGS ) Q1 2024 Earnings Conference Call April 29, 2024 4:30 PM ET Company Participants Sabrina Dunbar – Commercial Chief of Staff Katherine Stueland – President and Chief Executive Officer Kevin Feeley – Chief Financial Officer Conference Call Participants Daniel Brennan – TD Cowen Mark Massaro – BTIG, LLC Matthew Sykes – Goldman Sachs Matthew Stanton – Jefferies Group LLC Operator Ladies and gentlemen, thank you for standing by, and welcome to the GeneDx First Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Is It Worth Investing in GeneDx Holdings Corp (NASDAQ: WGS) Right Now?
Company’s 36-month beta value is 2.69.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for WGS is 16.22M, and currently, short sellers hold a 6.59% ratio of that floaft. The average trading volume of WGS on April 30, 2024 was 194.86K shares.
WGS’s Market Performance
WGS’s stock has seen a 35.22% increase for the week, with a 79.69% rise in the past month and a 330.40% gain in the past quarter. The volatility ratio for the week is 10.61%, and the volatility levels for the past 30 days are at 10.13% for GeneDx Holdings Corp The simple moving average for the past 20 days is 56.90% for WGS’s stock, with a 216.76% simple moving average for the past 200 days.
WGS Trading at 74.33% from the 50-Day Moving Average
After a stumble in the market that brought WGS to its low price for the period of the last 52 weeks, the company was able to rebound, for now settling with 29.08% of gains for the given period.
Volatility was left at 10.13%, however, over the last 30 days, the volatility rate increased by 10.61%, as shares surge +69.35% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +212.87% upper at present.
During the last 5 trading sessions, WGS rose by +31.67%, which changed the moving average for the period of 200-days by +135.12% in comparison to the 20-day moving average, which settled at $10.66. In addition, GeneDx Holdings Corp saw 490.03% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at WGS starting from Stueland Katherine, who sale 8,559 shares at the price of $10.59 back on Mar 18 ’24. After this action, Stueland Katherine now owns 66,698 shares of GeneDx Holdings Corp, valued at $90,661 using the latest closing price.
Feeley Kevin, the CHIEF FINANCIAL OFFICER of GeneDx Holdings Corp, sale 3,253 shares at $10.59 during a trade that took place back on Mar 18 ’24, which means that Feeley Kevin is holding 28,927 shares at $34,455 based on the most recent closing price.
Stock Fundamentals for WGS
Current profitability levels for the company are sitting at:
- -0.87 for the present operating margin
- 0.42 for the gross margin
The net margin for GeneDx Holdings Corp stands at -0.87. The total capital return value is set at -0.43. Equity return is now at value -72.97, with -34.50 for asset returns.
Based on GeneDx Holdings Corp (WGS), the company’s capital structure generated 0.2 points at debt to capital in total, while cash flow to debt ratio is standing at -3.17. The debt to equity ratio resting at 0.25. The interest coverage ratio of the stock is -74.44.
Currently, EBITDA for the company is -127.83 million with net debt to EBITDA at -0.17. When we switch over and look at the enterprise to sales, we see a ratio of 2.37. The receivables turnover for the company is 6.17for trailing twelve months and the total asset turnover is 0.43. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.10.
Conclusion
In a nutshell, GeneDx Holdings Corp (WGS) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
